skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Wednesday, December 25, 2013

Merry Christmas!


Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 4:32 AM

No comments:

Post a Comment

Newer Post Older Post Home
View mobile version
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2026 #2027 #2028

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2026

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2026 #2027 #2028

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Wellness Blog - NY Times
    Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
    7 hours ago
  • Government Executive
    OPM cuts degree requirements for government tech jobs in new standards
    9 hours ago
  • Medtech Insight
    Osteoboost Raises $8M To Scale FDA-Cleared Vibration Device For Osteopenia
    10 hours ago
  • GEN Biotech News
    Pregnancy Sickness Study Identifies New Genetic Links
    12 hours ago
  • Medscape Today Headlines
    HIV Treatment May Move Beyond Daily Pills With Injectables
    12 hours ago
  • FDA What's New: Drugs
    Information about Nitrosamine Impurities in Medications
    12 hours ago
  • eLearning Industry
    10 Problem-Solving Training Techniques Every Organization Should Use
    13 hours ago
  • The Incidental Economist
    I tried price shopping for health care. It isn’t worth it – not yet.
    14 hours ago
  • Pharmaceutical Commerce
    15 hours ago
  • BioPharma Dive - Latest News
    Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers
    16 hours ago
  • BioPharma Dive
    Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers
    16 hours ago
  • FierceBiotech: Medtech
    Labcorp launches rapid fentanyl test with 48-hour detection window
    16 hours ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about FDA seeking more data on a Lilly obesity pill, a pharma 340B win, and more
    18 hours ago
  • Science-Based Medicine
    New Study on AI Clinical Decision-Making
    19 hours ago
  • Clarkston Consulting
    Strengthening Project Outcomes Through the Power of a Premortem
    20 hours ago
  • Drug & Device Law
    Third Circuit Upholds Rule 702 Admissibility of Probabilistic Genotype Evidence
    20 hours ago
  • FierceBiotech
    FDA advisory committee set to weigh taking action on certain unapproved peptides
    20 hours ago
  • FiercePharma
    FDA advisory committee set to weigh taking action on certain unapproved peptides
    20 hours ago
  • All Kaiser Health News
    Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
    23 hours ago
  • Marler Blog
    Good Brain Tonic recalled due to Botulism
    1 day ago
  • JD Supra Law News
    The Pitch - March 2026
    1 day ago
  • FDA - Press Releases
    FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
    1 day ago
  • CNBC Health Care
    Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
    1 day ago
  • Drug Channels
    Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update
    1 day ago
  • Clinical Correlations
    To Treat or Not to Treat: Rethinking the Positive Urine Culture
    5 days ago
  • Pharmafile
    Sandoz launches allergy relief nasal spray in Germany and Switzerland
    6 days ago
  • Pharmafile - Mfg & Production
    Trelleborg to take part in Medtec Japan 2026
    1 week ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    1 week ago
  • Food Poison Journal
    Hawaii Health warns of E. coli in Raw Farm Cheddar Cheese
    1 week ago
  • Asbestos and Mesothelioma News
    Global Asbestos Awareness Week Puts a Worldwide Crisis in Focus
    1 week ago
  • Eye on FDA
    Is cooking with olive oil really beneficial for your health? Expert Answers
    3 weeks ago
  • Quality Matters
    Leveraging surface sampling performance data to strengthen environmental monitoring
    3 weeks ago
  • The Compliance and Ethics Blog
    The 45-Day Trap: Why Technical Documentation Gaps are the New Frontline of Hospice Audits
    3 weeks ago
  • World Pharma - Breaking News
    Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
    5 weeks ago
  • Ted Eytan, MD
    San Juan, Puerto Rico
    5 weeks ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    3 months ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    4 months ago
  • 33 Charts
    The AI coding arms race
    5 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    9 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    10 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    10 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    10 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    1 year ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    1 year ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    1 year ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    2 years ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    2 years ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ▼  December (7)
      • Merry Christmas!
      • Report: Christmas will kill you | National Monitor
      • We Moved Forward on Many Fronts This Year | FDA Voice
      • Expert Panel Want BP Cuffs Loosened - MedPage Today
      • FDA Drug Quality and Security Act Stakeholder Disc...
      • Procedure Writing Course
      • Nanotech Roundup: Latest National Nanotechnology I...
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo